https://pubmed.ncbi.nlm.nih.gov/40223119/
The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative...
Indisulam is a promising therapeutic candidate for AMKL and the RBM39-mediated ZMYND8 splicing plays an important role in promoting the development of AMKL.
degrader
https://pubmed.ncbi.nlm.nih.gov/7589286/?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line,...
A novel fibroblast-dependent human immature megakaryoblastic leukemia cell line (M-MOK) was established from the bone marrow of a girl with acute...
of a